Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol

Br J Dermatol. 2013 Jan;168(1):222-4. doi: 10.1111/j.1365-2133.2012.11131.x. Epub 2012 Oct 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adrenergic beta-Antagonists / administration & dosage*
  • Drug Administration Schedule
  • Feasibility Studies
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Hemangioma / drug therapy*
  • Humans
  • Infant
  • Male
  • Nadolol / administration & dosage*
  • Propranolol / administration & dosage*
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Nadolol
  • Propranolol